QCM
IRWD icon

Quantinno Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Quantinno Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Buy
150,604
+20,901
+16% +$80.6K ﹤0.01% 2859
2026
Q1 		$455K Buy
129,703
+10,810
+9% +$44.3K ﹤0.01% 2780
2025
Q4 		$401K Buy
+118,893
New +$309K ﹤0.01% 2635
2024
Q4 		– Sell
-19,191
Closed -$79.1K – 1663
2024
Q3 		$79.1K Buy
19,191
+5,482
+40% +$29.5K ﹤0.01% 1449
2024
Q2 		$89.4K Buy
+13,709
New +$97K ﹤0.01% 1300
2019
Q1 		– Sell
-15,054
Closed -$131K – 423
2018
Q4 		$131K Buy
+15,054
New +$173K 0.11% 334

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quantinno Capital Management's IRWD Position: Q2 2026 in Review

Quantinno Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 16% in Q2 2026, buying an estimated $80.6K and bringing the position to 150,604 shares worth $634K. The position accounts for ﹤0.01% of the portfolio, ranked #2859.

Quantinno Capital Management first reported a position in IRWD in Q4 2018 and has held it in 6 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Quantinno Capital Management held 150,604 shares of Ironwood Pharmaceuticals worth $634K as of Q2 2026.
  • Quantinno Capital Management bought 20,901 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $80.6K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2859 holding.
  • Quantinno Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2018 and has held it in 6 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.